MIPL-Logo

3decades

 

MIRA INFORM REPORT

 

 

Report No. :

487124

Report Date :

20.01.2018

 

IDENTIFICATION DETAILS

 

Name :

MATERIAS PRIMAS FARMACEUTICAS SRL

 

 

Registered Office :

C/Jatfres Esq Beisbolista, Santo Domingo, Distrito Nacional, frente a la ferretería La Innovación

 

 

Country :

Dominican Republic

 

 

Date of Incorporation :

1994

 

 

Legal Form :

Sociedad de Responsabilidad Limitada

 

 

Line of Business :

Import And Distribution Of Raw Material For Pharmaceutical, Food And Veterinary Products

 

 

No. of Employees :

45

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

A

 

Credit Rating

Explanation

Rating Comments

A

Acceptable Risk

Business dealings permissible with moderate risk of default

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List

 

Country Name

Previous Rating

(30.06.2017)

Current Rating

(30.09.2017)

Dominican Republic

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low Risk

 

A2

Moderately Low Risk

 

B1

Moderate Risk

 

B2

Moderately High Risk

 

C1

High Risk

 

C2

Very High Risk

 

D

 


 

DOMINICAN REPUBLIC - ECONOMIC OVERVIEW

 

The Dominican Republic was for most of its history primarily an exporter of sugar, coffee, and tobacco, but in recent years the service sector has overtaken agriculture as the economy's largest employer, due to growth in construction, tourism, and free trade zones. The mining sector has also played a greater role in the export market since late 2012 with the commencement of the extraction phase of the Pueblo Viejo Gold and Silver mine, one of the largest gold mines in the world. The country suffers from marked income inequality; the poorest half of the population receives less than one-fifth of GDP, while the richest 10% enjoys nearly 40% of GDP. High unemployment, a large informal sector, and underemployment remain important long-term challenges.

The economy is highly dependent upon the US, the destination for approximately half of exports. Remittances from the US amount to about 7% of GDP, equivalent to about a third of exports and two-thirds of tourism receipts. The Central America-Dominican Republic Free Trade Agreement came into force in March 2007, boosting investment and manufacturing exports.

The Dominican Republic's economy rebounded from the global recession in 2010-16, and the fiscal situation is improving. A tax reform package passed in November 2012, a reduction in government spending, and lower energy costs helped to narrow the central government budget deficit from 6.6% of GDP in 2012 to 2.6% in 2016. A liability management operation in January 2015, in which the government paid down over $4 billion of the country’s Petrocaribe debt at a discount of 52% with proceeds from the sale of $2.5 billion in global bonds, reduced the country’s debt load by approximately by 4% of GDP. Since 2015 the Dominican Republic has posted the fastest economic growth in Latin America.

 

Source : CIA

 


 

STATUTORY INFORMATION

Legal Name:

MATERIAS PRIMAS FARMACEUTICAS SRL

Trade Name:

MAPRIFARMA SRL

RNC:

101744111

Date Created:

1994

Date Incorporated:

1997

Legal Address:

C/Jatfres Esq Beisbolista

Santo Domingo, Distrito Nacional, frente a la ferretería La Innovación

República Dominicana

Operative Address:

C/Jatfres Esq Beisbolista

Santo Domingo, Distrito Nacional, frente a la ferretería La Innovación

República Dominicana

Telephone:

1(809)-5312520

Fax:

1(809)-5312520

Legal Form:

Sociedad de Responsabilidad Limitada

Email:

maprifarma@hotmail.com

Registered in:

Dominican Republic

Website:

www.maprifarma.com.do

Manager:

Miguel Gutierrez, President

Staff:

45

Activity:

Chemical Wholesalers Industry

SIC Codes:

5162 5169

NAICS Codes:

424610 424690

BANKS

Name of the Bank:

BANCO POPULAR

The company does not make its banking information public

HISTORY

The company started business in 1994

 

PRINCIPAL ACTIVITY

The company is dedicated to the import and distribution of raw material for pharmaceutical, food and veterinary products

Products/Services description:

Raw Pharmaceutical Materials

Trademarks:

DI LIRIO LAPICES DE LABIOS
LABELLO MED PROTECTOR DE LABIOS

Sales are:

Wholesale

Clients:

CARIBBEAN MULTI PRODUCTS INC.
Puerto Rico

Pharmaceutical Dugstores
Chemicals Stores

Competitors:

BASF Dominicana, S.A
Laboratorio Sugar,  S.R.L.
Laboratorios Bio-Médica S.A.

Suppliers:

Clariant (Mexico) S.A. De C.V.

Mexico

 

Schott Envases Farmaceuticos S.A.

Colombia

 

Arrow Chemical Group Corp.

China

 

K.D. Feddersen GmbH & Co. KG

Germany

Operations area:

National

The company imports from

Mexico, USA, Colombia, South Africa, Germany, China

The company exports to

Caribbean

The subject employs

45 people

Payments:

No Complaints

 

 

LOCATION

Headquarters :

C/Jatfres Esq Beisbolista

Santo Domingo, Distrito Nacional, frente a la ferretería La Innovación

República Dominicana

Branches:

 

Related Companies:

The company does not have branches registered

 

Reactivos Analíticos D.S., SRL

C/Jatfres Esq Beisbolista

Santo Domingo, Distrito Nacional

República Dominicana

Business Overview:

Companies in this industry distribute plastics materials, alkalis and chlorine, detergents and soaps, adhesives, and industrial gases.

Chemical distribution is a cyclical business dependent on industrial demand. The profitability of individual companies depends on an efficient distribution system. Larger companies can offer more products and services.

Major products are plastics materials, alkalis and chlorine, detergents and soaps, adhesives, and industrial gases.

 

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

Listed at the stock exchange:

NA

Capital:

NA

Shareholders %:

This is a prívate company. The main shareholder is:

 

Sr. Miguel de los Santos Gutierrez Salcedo.

Management:

Miguel Gutierrez, President

Ana Zunilda Veras, Vicepresident

Mabelle Peña, Accoutant

Yolibel Rodriguez, Administrative

Related Companies:

Reactivos Analiticos DS S R L

 

 

FINANCIAL INFORMATION

 

This is a private company which does not make its financial information public. The following information has been provided by outside sources.

Currency

USD

Year

2016

Revenue

2 500 000

Cash Flow

NORMAL

LEGAL FILINGS

 

No legal/criminal were connected to the subject

SUMMARY

MATERIA PRIMA FARMACEUTICA SRL is a Dominican Republic company dedicated to the distribution of pharmaceutical products with 21 years of experience in the market.

The company has a small sized structure with the support of 45 employees.

It is well established in the business and shows no negative records.

 

 

 

RISK INFORMATION

Payments

No Complaints

Cash

Normal

Indebtedness

Controlled

CALL

INTERVIEWEE

Elizabeth Ascensio

POSITION

Administrative

COMMENTS

She confirmed RNC, name, staff number, managers, ownership, experience, complete address and activity.

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

INR 63.72

UK Pound

1

INR 88.64

Euro

1

INR 78.14

DOP

1

INR 1.31

 

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

DIV

 

 

Report Prepared by :

KET

                                                


 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.